Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Cardiology Fellowship, Medicine, Duke University School of Medicine 2013 - 2017
  • Global Women's Health Fellowship, Brigham and Women's Hospital 2011 - 2013
  • M.P.H., Harvard University 2013
  • Intership And Residency In Internal Medicine, Brigham and Women's Hospital 2008 - 2011
  • M.D., Harvard Medical School 2008
• Research
• 

  Selected Grants

  • QuBBD: Deep Poisson Methods for Biomedical Time-to-Event and Longitudinal Data  awarded by National Institutes of Health 2017 - 2020
  • Cardiovascular Risk Profile of LAL Deficiency Patients  awarded by Alexion Pharmaceuticals, Inc. 2016 - 2017
• Publications & Artistic Works
• 

  Selected Publications

  • Journal Articles

    • Pagidipati, NJ, Navar, AM, Pieper, KS, Green, JB, Bethel, MA, Armstrong, PW, Josse, RG, McGuire, DK, Lokhnygina, Y, Cornel, JH, Halvorsen, S, Strandberg, TE, Delibasi, T, Holman, RR, Peterson, and ED, TECOS Study Group , . "Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes: International Insights from the TECOS Trial." Circulation (June 16, 2017).  Full Text
    • Mentz, RJ, Bethel, MA, Gustavson, S, Thompson, VP, Pagidipati, NJ, Buse, JB, Chan, JC, Iqbal, N, Maggioni, AP, Marso, SP, Ohman, P, Poulter, N, Ramachandran, A, Zinman, B, Hernandez, AF, and Holman, RR. "Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)." American heart journal 187 (May 2017): 1-9.  Full Text
    • Pagidipati, NJ, Hess, CN, Clare, RM, Akerblom, A, Tricoci, P, Wojdyla, D, Keenan, RT, James, S, Held, C, Mahaffey, KW, Klein, AB, Wallentin, L, and Roe, MT. "An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome." American heart journal 187 (May 2017): 53-61.  Full Text
    • Pagidipati, NJ, Navar, AM, Mulder, H, Sniderman, AD, Peterson, ED, and Pencina, MJ. "Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines." JAMA 317, no. 15 (April 2017): 1563-1567.  Full Text
    • Pagidipati, NJ, and Granger, CB. "Guideline: The USPSTF recommends low- to moderate-dose statins to prevent CVD in selected adults 40 to 75 years of age." Annals of internal medicine 166, no. 6 (March 2017): JC26-.  Full Text
    • Pagidipati, NJ, and Douglas, PS. "The Puzzle of Noninvasive Testing in Women: Filling in the Pieces With the CRESCENT Trial (Calcium Imaging and Selective CT Angiography in Comparison to Functional Testing for Suspected Coronary Artery Disease)." Circulation. Cardiovascular imaging 10, no. 2 (February 2017).  Full Text
    • Pagidipati, NJ, and Peterson, ED. "Acute coronary syndromes in women and men." Nature reviews. Cardiology 13, no. 8 (August 2016): 471-480. (Review)  Full Text
    • Pagidipati, NJ, Hemal, K, Coles, A, Mark, DB, Dolor, RJ, Pellikka, PA, Hoffmann, U, Litwin, SE, Udelson, J, Daubert, MA, Shah, SH, Martinez, B, Lee, KL, and Douglas, PS. "Sex Differences in Functional and CT Angiography Testing in Patients With Suspected Coronary Artery Disease." Journal of the American College of Cardiology 67, no. 22 (June 2016): 2607-2616.  Full Text
    • Pagidipati, NJ, Pencina, M, and Sniderman, AD. "The Enigma of Glucose and Lipid Metabolism." JAMA Cardiology 1, no. 2 (May 1, 2016): 145-145.  Full Text
    • Hemal, K, Pagidipati, NJ, Coles, A, Dolor, RJ, Mark, DB, Pellikka, PA, Hoffmann, U, Litwin, SE, Daubert, MA, Shah, SH, Ariani, K, Bullock-Palmer, RP, Martinez, B, Lee, KL, and Douglas, PS. "Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial." JACC. Cardiovascular imaging 9, no. 4 (April 2016): 337-346.  Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.